|
1
|
Camfield P and Camfield C: Incidence,
prevalence and aetiology of seizures and epilepsy in children.
Epileptic Disord. 17:117–123. 2015.PubMed/NCBI
|
|
2
|
Carod-Artal FJ and Vázquez-Cabrera CB: An
anthropological study about epilepsy in native tribes from Central
and South America. Epilepsia. 48:886–893. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
López González FJ, Rodríguez Osorio X,
Gil-Nagel Rein A, Carreño Martínez M, Serratosa Fernández J,
Villanueva Haba V, Donaire Pedraza AJ and Mercadé Cerdá JM:
Drug-resistant epilepsy: Definition and treatment alternatives.
Neurologia. 30:439–446. 2015.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fisher RS, Acevedo C, Arzimanoglou A,
Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn
M, et al: ILAE official report: A practical clinical definition of
epilepsy. Epilepsia. 55:475–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Golyala A and Kwan P: Drug development for
refractory epilepsy: The past 25 years and beyond. Seizure.
44:147–156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Falco-Walter JJ, Scheffer IE and Fisher
RS: The new definition and classification of seizures and epilepsy.
Epilepsy Res. 139:73–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scheffer IE, Berkovic S, Capovilla G,
Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW,
Moshé SL, et al: ILAE classification of the epilepsies: Position
paper of the ILAE commission for classification and terminology.
Epilepsia. 58:512–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Waldbaum S and Patel M: Mitochondria,
oxidative stress, and temporal lobe epilepsy. Epilepsy Res.
88:23–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carmona-Aparicio L, Pérez-Cruz C,
Zavala-Tecuapetla C, Granados-Rojas L, Rivera-Espinosa L,
Montesinos-Correa H, Hernández-Damián J, Pedraza-Chaverri J,
Sampieri A III, Coballase-Urrutia E, et al: Overview of Nrf2 as
therapeutic target in epilepsy. Int J Mol Sci. 16:18348–18367.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cardenas-Rodriguez N, Coballase-Urrutia E,
Pérez-Cruz C, Montesinos-Correa H, Rivera-Espinosa L, Sampieri A
III and Carmona-Aparicio L: Relevance of the glutathione system in
temporal lobe epilepsy: Evidence in human and experimental models.
Oxid Med Cell Longev. 2014:7592932014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Floriano-Sánchez E, Brindis F,
Ortega-Cuellar D, Ignacio-Mejia I, Moreno-Arriola E, Romero-Morelos
P, Ceballos-Vasquez E, Cordova-Espinoza MG, Arregoitia-Sarabia CK,
Sandoval- Pacheco R, et al: Differential gene expression profile
induced by valproic acid (VPA) in pediatric epileptic patients.
Genes (Basel). 9(pii): E3282018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Köhling R: Voltage-gated sodium channels
in epilepsy. Epilepsia. 43:1278–1295. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan NC, Mulley JC and Berkovic SF: Genetic
association studies in epilepsy: ‘The truth is out there’.
Epilepsia. 45:1429–1442. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Semah F and Ryvlin P: Can we predict
refractory epilepsy at the time of diagnosis? Epileptic Disord. 7
(Suppl 1):S10–S13. 2005.PubMed/NCBI
|
|
15
|
Fishman MC and Porter JA: Pharmaceuticals:
A new grammar for drug discovery. Nature. 437:491–493. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kwan P, Arzimanoglou A, Berg AT, Brodie
MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S and
French J: Definition of drug resistant epilepsy: Consensus proposal
by the ad hoc task force of the ILAE commission on therapeutic
strategies. Epilepsia. 51:1069–1077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kwan P and Brodie MJ: Early identification
of refractory epilepsy. N Engl J Med. 342:314–319. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brodie MJ, Barry SJ, Bamagous GA, Norrie
JD and Kwan P: Patterns of treatment response in newly diagnosed
epilepsy. Neurology. 78:1548–1554. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Picot MC, Baldy-Moulinier M, Daurès JP,
Dujols P and Crespel A: The prevalence of epilepsy and
pharmacoresistant epilepsy in adults: A population-based study in a
Western European country. Epilepsia. 49:1230–1238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ngugi AK, Bottomley C, Kleinschmidt I,
Sander JW and Newton CR: Estimation of the burden of active and
life-time epilepsy: A meta-analytic approach. Epilepsia.
51:883–890. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zavala-Tecuapetla C, Sampieri A III,
Calderón-Guzmán D and Carmona-Aparicio L: Principales mecanismos de
acción farmacológica en las crisis epilépticas díficiles de
estabilizar. Acta Pediátr México. 32:125–127. 2011.
|
|
22
|
Espinosa-Jovel CA and Sobrino-Mejia FE:
Drug resistant epilepsy. Clinical and neurobiological concepts. Rev
Neurol. 61:159–166. 2015.(In Spanish). PubMed/NCBI
|
|
23
|
Luoni C, Bisulli F, Canevini MP, De Sarro
G, Fattore C, Galimberti CA, Gatti G, La Neve A, Muscas G, Specchio
LM, et al: Determinants of health-related quality of life in
pharmacoresistant epilepsy: Results from a large multicenter study
of consecutively enrolled patients using validated quantitative
assessments. Epilepsia. 52:2181–2191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Argumosa A and Herranz J: La repercusión
económica de las enfermedades crónicas: El coste de la epilepsia
infantil en el año 2000. Bol Pediatr. 41:23–29. 2001.
|
|
25
|
Martin K, Jackson CF, Levy RG and Cooper
PN: Ketogenic diet and other dietary treatments for epilepsy.
Cochrane Database Syst Rev. 2:CD0019032016.PubMed/NCBI
|
|
26
|
Chudomelova L, Scantlebury MH, Raffo E,
Coppola A, Betancourth D and Galanopoulou AS: Modeling new
therapies for infantile spasms. Epilepsia. 51 (Suppl 3):S27–S33.
2010. View Article : Google Scholar
|
|
27
|
Baumgartner C, Koren JP, Britto-Arias M,
Zoche L and Pirker S: Presurgical epilepsy evaluation and epilepsy
surgery. F1000Res. 8(pii): F1000 Faculty Rev-1818. 2019.PubMed/NCBI
|
|
28
|
Ułamek-Kozioł M, Czuczwar SJ, Januszewski
S and Pluta R: Ketogenic diet and epilepsy. Nutrients. 11(pii):
E25102019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boon P, De Cock E, Mertens A and Trinka E:
Neurostimulation for drug-resistant epilepsy: A systematic review
of clinical evidence for efficacy, safety, contraindications and
predictors for response. Curr Opin Neurol. 31:198–210. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
García-Contreras F, Constantino-Casas P,
Castro-Ríos A, Nevárez-Sida A, Estrada Correa Gdel C, Carlos Rivera
F, Guzmán-Caniupan J, Torres-Arreola Ldel P, Contreras- Hernández
I, Mould-Quevedo J and Garduño-Espinosa J: Direct medical costs for
partial refractory epilepsy in Mexico. Arch Med Res. 37:376–383.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aguirre-Velázquez CG: Report from a survey
of parents regarding the use of cannabidiol (Medicinal cannabis) in
Mexican children with refractory epilepsy. Neurol Res Int.
2017:29857292017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Younus I and Reddy DS: A resurging boom in
new drugs for epilepsy and brain disorders. Expert Rev Clin
Pharmacol. 11:27–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang F, Hartz AMS and Bauer B:
Drug-resistant epilepsy: Multiple hypotheses, few answers. Front
Neurol. 8:3012017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Myers CT and Mefford HC: Advancing
epilepsy genetics in the genomic era. Genome Med. 7:912015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Depondt C: The potential of
pharmacogenetics in the treatment of epilepsy. Eur J Paediatr
Neurol. 10:57–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mulley JC and Dibbens LM: Genetic
variations and associated pathophysiology in the management of
epilepsy. Appl Clin Genet. 4:113–125. 2011.PubMed/NCBI
|
|
37
|
Noebels J: Pathway-driven discovery of
epilepsy genes. Nat Neurosci. 18:344–350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Devinsky O: Patients with refractory
seizures. N Engl J Med. 340:1565–1570. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pal DK and Greenberg DA: Evaluating
genetic heterogeneity in complex disorders. Hum Hered. 53:216–226.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Wen Y, Zhang Q, Yu S, Chen Y, Wu
X, Zhang Y and Bao X: Gene mutational analysis in a cohort of
Chinese children with unexplained epilepsy: Identification of a new
KCND3 phenotype and novel genes causing Dravet syndrome. Seizure.
66:26–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fernández-Marmiesse A, Sánchez-Iglesias S,
Darling A, O'Callaghan MM, Tonda R, Jou C and Araújo-Vilar D: A de
novo heterozygous missense BSCL2 variant in 2 siblings with
intractable developmental and epileptic encephalopathy. Seizure.
71:161–165. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Coughlin CR II, Swanson MA, Spector E,
Meeks NJL, Kronquist KE, Aslamy M, Wempe MF, van Karnebeek CDM,
Gospe SM Jr, Aziz VG, et al: The genotypic spectrum of ALDH7A1
mutations resulting in pyridoxine dependent epilepsy: A common
epileptic encephalopathy. J Inherit Metab Dis. 42:353–361. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Angione K, Eschbach K, Smith G, Joshi C
and Demarest S: Genetic testing in a cohort of patients with
potential epilepsy with myoclonic-atonic seizures. Epilepsy Res.
150:70–77. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wolff M, Johannesen KM, Hedrich UBS,
Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard
L, et al: Genetic and phenotypic heterogeneity suggest therapeutic
implications in SCN2A-related disorders. Brain. 140:1316–1336.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kang JQ and Macdonald RL: Molecular
pathogenic basis for GABRG2 mutations associated with a spectrum of
epilepsy syndromes, from generalized absence epilepsy to dravet
syndrome. JAMA Neurol. 73:1009–1016. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Møller RS, Wuttke TV, Helbig I, Marini C,
Johannesen KM, Brilstra EH, Vaher U, Borggraefe I, Talvik I, Talvik
T, et al: Mutations in GABRB3: From febrile seizures to epileptic
encephalopathies. Neurology. 88:483–492. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Johannesen KM, Gardella E, Linnankivi T,
Courage C, de Saint Martin A, Lehesjoki AE, Mignot C, Afenjar A,
Lesca G, Abi-Warde MT, et al: Defining the phenotypic spectrum of
SLC6A1 mutations. Epilepsia. 59:389–402. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ortega-Moreno L, Giráldez BG, Soto-Insuga
V, Losada-Del Pozo R, Rodrigo-Moreno M, Alarcón-Morcillo C,
Sánchez- Martín G, Díaz-Gómez E, Guerrero-López R, Serratosa JM, et
al: Molecular diagnosis of patients with epilepsy and developmental
delay using a customized panel of epilepsy genes. PLoS One.
12:e01889782017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Steinlein OK: Gene polymorphisms and their
role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch
Pharmacol. 382:109–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Esmaeilzadeh H, Farjadian S, Alyasin S,
Nemati H, Nabavizadeh H and Esmaeilzadeh E: Epidemiology of severe
cutaneous adverse drug reaction and its HLA association among
pediatrics. Iran J Pharm Res. 18:506–522. 2019.PubMed/NCBI
|
|
51
|
Yang X, Yan Y, Fang S, Zeng S, Ma H, Qian
L, Chen X, Wei J, Gong Z and Xu Z: Comparison of oxcarbazepine
efficacy and MHD concentrations relative to age and BMI:
Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
Medicine (Baltimore). 98:e149082019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huang J, Qian Z, Chen H, Huang Q, Huang L,
Liu G and Tang X: Association of single nucleotide polymorphisms of
SCN1A gene with therapeutic effect of carbamazepine among ethnic
Zhuang Chinese patients with epilepsy. Zhonghua Yi Xue Yi Chuan Xue
Za Zhi. 36:271–274. 2019.(In Chinese). PubMed/NCBI
|
|
53
|
Shi L, Zhu M, Li H, Wen Z, Chen X, Luo J,
Lin C and Zhang Z: SCN1A and SCN2A polymorphisms are associated
with response to valproic acid in Chinese epilepsy patients. Eur J
Clin Pharmacol. 75:655–663. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Feng W, Mei S, Han J, Zhu L, Yu Y, Gao B,
Wu Y, Li J, Zhao Z and Fang F: Lack of association between valproic
acid response and polymorphisms of its metabolism, transport, and
receptor genes in children with focal seizures. Neurol Sci.
40:523–528. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Suzuki T, Mihara K, Nagai G, Kagawa S,
Nakamura A, Nemoto K and Kondo T: Relationship between UGT1A4 and
UGT2B7 polymorphisms and the steady-state plasma concentrations of
lamotrigine in patients with treatment-resistant depressive
disorder receiving lamotrigine as augmentation therapy. Ther Drug
Monit. 41:86–90. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li Z and Wang Y: Relationship between
UGT1A4 142T>G polymorphism and serum concentration of
lamotrigine in Chinese epileptic patients: A meta-analysis.
Zhonghua Yi Xue Za Zhi. 98:3365–3370. 2018.(In Chinese). PubMed/NCBI
|
|
57
|
Gailite L, Rots D, Pukite I, Cernevska G
and Kreile M: Case report: Multiple UGT1A1 gene variants in a
patient with Crigler-Najjar syndrome. BMC Pediatr. 18:3172018.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Feng W, Mei S, Zhu L, Yu Y, Yang W, Gao B,
Wu X, Zhao Z and Fang F: Effects of UGT2B7, SCN1A and CYP3A4 on the
therapeutic response of sodium valproate treatment in children with
generalized seizures. Seizure. 58:96–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu L, Zhao L, Wang Q, Qiu F, Wu X and Ma
Y: Influence of valproic acid concentration and polymorphism of
UGT1A4*3, UGT2B7-161C > T and UGT2B7*2 on serum concentration of
lamotrigine in Chinese epileptic children. Eur J Clin Pharmacol.
71:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sun YX, Zhuo WY, Lin H, Peng ZK, Wang HM,
Huang HW, Luo YH and Tang FQ: The influence of UGT2B7 genotype on
valproic acid pharmacokinetics in Chinese epilepsy patients.
Epilepsy Res. 114:78–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kousar S, Wafai ZA, Wani MA, Jan TR and
Andrabi KI: Clinical relevance of genetic polymorphism in CYP2C9
gene to pharmacodynamics and pharmacokinetics of phenytoin in
epileptic patients: Validatory pharmacogenomic approach to
pharmacovigilance. Int J Clin Pharmacol Ther. 53:504–516. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhu X, Yun W, Sun X, Qiu F, Zhao L and Guo
Y: Effects of major transporter and metabolizing enzyme gene
polymorphisms on carbamazepine metabolism in Chinese patients with
epilepsy. Pharmacogenomics. 15:1867–1879. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Reimers A, Sjursen W, Helde G and
Brodtkorb E: Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their
effects on serum concentrations of lamotrigine. Eur J Drug Metab
Pharmacokinet. 41:149–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Berghuis B, Stapleton C, Sonsma ACM, Hulst
J, de Haan GJ, Lindhout D, Demurtas R, EpiPGX Consortium, Krause R,
Depondt C, et al: A genome-wide association study of sodium levels
and drug metabolism in an epilepsy cohort treated with
carbamazepine and oxcarbazepine. Epilepsia Open. 4:102–109. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Berghuis B, van der Palen J, de Haan GJ,
Lindhout D, Koeleman BPC and Sander JW; EpiPGX Consortium, :
Carbamazepine- and oxcarbazepine-induced hyponatremia in people
with epilepsy. Epilepsia. 58:1227–1233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
McCormack M, Gui H, Ingason A, Speed D,
Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, et
al: Genetic variation in CFH predicts phenytoin-induced
maculopapular exanthema in European-descent patients. Neurology.
90:e332–e341. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bai X, Xu C, Wen D, Chen Y, Li H, Wang X,
Zhou L, Huang M and Jin J: Polymorphisms of peroxisome
proliferator-activated receptor γ (PPARγ) and cluster of
differentiation 36 (CD36) associated with valproate-induced obesity
in epileptic patients. Psychopharmacology (Berl). 235:2665–2673.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li H, Wang X, Zhou Y, Ni G, Su Q, Chen Z,
Chen Z, Li J, Chen X, Hou X, et al: Association of LEPR and ANKK1
gene polymorphisms with weight gain in epilepsy patients receiving
valproic acid. Int J Neuropsychopharmacol. 18:pyv0212015.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang C, Wang P, Yang LP, Pan J, Yang X and
Ma HY: Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene
polymorphisms with adverse effects of valproic acid in Chinese
patients with epilepsy. Epilepsy Res. 132:64–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Manna I, Gambardella A, Bianchi A, Striano
P, Tozzi R, Aguglia U, Beccaria F, Benna P, Campostrini R, Canevini
MP, et al: A functional polymorphism in the SCN1A gene does not
influence antiepileptic drug responsiveness in Italian patients
with focal epilepsy. Epilepsia. 52:e40–e44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kothur K, Holman K, Farnsworth E, Ho G,
Lorentzos M, Troedson C, Gupta S, Webster R, Procopis PG, Menezes
MP, et al: Diagnostic yield of targeted massively parallel
sequencing in children with epileptic encephalopathy. Seizure.
59:132–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Fang ZX, Zhang M, Xie LL, Jiang L, Hong
SQ, Li XJ, Hu Y and Chen J: KCNQ2 related early-onset epileptic
encephalopathies in Chinese children. J Neurol. 266:2224–2232.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Goto A, Ishii A, Shibata M, Ihara Y,
Cooper EC and Hirose S: Characteristics of KCNQ2 variants causing
either benign neonatal epilepsy or developmental and epileptic
encephalopathy. Epilepsia. 60:1870–1880. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kuersten M, Tacke M, Gerstl L, Hoelz H,
Stülpnagel CV and Borggraefe I: Antiepileptic therapy approaches in
KCNQ2 related epilepsy: A systematic review. Eur J Med Genet.
63:1036282020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Al-Eitan LN, Al-Dalalah IM, Elshammari AK,
Khreisat WH and Almasri AY: The impact of potassium channel gene
polymorphisms on antiepileptic drug responsiveness in Arab patients
with epilepsy. J Pers Med. 8(pii): E372018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Howell KB, McMahon JM, Carvill GL,
Tambunan D, Mackay MT, Rodriguez-Casero V, Webster R, Clark D,
Freeman JL, Calvert S, et al: SCN2A encephalopathy: A major cause
of epilepsy of infancy with migrating focal seizures. Neurology.
85:958–966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Turkdogan D, Thomas G and Demirel B:
Ketogenic diet as a successful early treatment modality for SCN2A
mutation. Brain Dev. 41:389–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Li X, Zhang J, Wu X, Yan H, Zhang Y, He
RH, Tang YJ, He YJ, Tan D, Mao XY, et al: Polymorphisms of ABAT,
SCN2A and ALDH5A1 may affect valproic acid responses in the
treatment of epilepsy in Chinese. Pharmacogenomics. 17:2007–2014.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Al-Eitan LN, Al-Dalalah IM and Aljamal HA:
Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic
drugs responsiveness and epilepsy susceptibility. Saudi Pharm J.
27:731–737. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Demarest ST and Brooks-Kayal A: From
molecules to medicines: The dawn of targeted therapies for genetic
epilepsies. Nat Rev Neurol. 14:735–745. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Murray S, Labbé S, Kothare S, Málaga I,
Kluger G, Ogden P, Lazure P and Arzimanoglou A: Identifying the
educational needs of physicians in pediatric epilepsy in order to
improve care: Results from a needs assessment in Germany, Spain,
and the United States. Epileptic Disord. 20:239–256.
2018.PubMed/NCBI
|
|
82
|
Striano P, Vari MS, Mazzocchetti C,
Verrotti A and Zara F: Management of genetic epilepsies: From
empirical treatment to precision medicine. Pharmacol Res.
107:426–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sánchez Alvarez JC, Serrano Castro PJ and
Serratosa Fernández JM: Clinical implications of mechanisms of
resistance to antiepileptic drugs. Neurologist. 13 (Suppl
1):S38–S46. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Cardenas-Rodriguez N, Huerta-Gertrudis B,
Rivera-Espinosa L, Montesinos-Correa H, Bandala C, Carmona-Aparicio
L and Coballase-Urrutia E: Role of oxidative stress in refractory
epilepsy: Evidence in patients and experimental models. Int J Mol
Sci. 14:1455–1476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Trivisano M, Terracciano A, Milano T,
Cappelletti S, Pietrafusa N, Bertini ES, Vigevano F and Specchio N:
Mutation of CHRNA2 in a family with benign familial infantile
seizures: Potential role of nicotinic acetylcholine receptor in
various phenotypes of epilepsy. Epilepsia. 56:e53–e57. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang MY, Liu XZ, Wang J and Wu LW: A novel
mutation of the nicotinic acetylcholine receptor gene CHRNA4 in a
Chinese patient with non-familial nocturnal frontal lobe epilepsy.
Epilepsy Res. 108:1927–1931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Villa C, Colombo G, Meneghini S, Gotti C,
Moretti M, Ferini-Strambi L, Chisci E, Giovannoni R, Becchetti A
and Combi R: CHRNA2 and nocturnal frontal lobe epilepsy:
Identification and characterization of a novel loss of function
mutation. Front Mol Neurosci. 12:172019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Goldberg-Stern H, Kaufmann R, Kivity S,
Afawi Z and Heron SE: Novel mutation in KCNQ2 causing benign
familial neonatal seizures. Pediatr Neurol. 41:367–370. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Chen DY, Chowdhury S, Farnaes L, Friedman
JR, Honold J, Dimmock DP and Gold OBOTRIJJ: Rapid diagnosis of
KCNQ2-associated early infantile epileptic encephalopathy improved
outcome. Pediatr Neurol. 86:69–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Allen NM, Mannion M, Conroy J, Lynch SA,
Shahwan A, Lynch B and King MD: The variable phenotypes of
KCNQ-related epilepsy. Epilepsia. 55:e99–e105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Piro E, Nardello R, Gennaro E, Fontana A,
Taglialatela M, Donato Mangano G, Corsello G and Mangano S: A novel
mutation in KCNQ3-related benign familial neonatal epilepsy:
Electroclinical features and neurodevelopmental outcome. Epileptic
Disord. 21:87–91. 2019.PubMed/NCBI
|
|
92
|
Miceli F, Striano P, Soldovieri MV,
Fontana A, Nardello R, Robbiano A, Bellini G, Elia M, Zara F,
Taglialatela M and Mangano S: A novel KCNQ3 mutation in familial
epilepsy with focal seizures and intellectual disability.
Epilepsia. 56:e15–e20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lehman A, Thouta S, Mancini GMS, Naidu S,
van Slegtenhorst M, McWalter K, Person R, Mwenifumbo J, Salvarinova
R; CAUSES Study, ; et al: Loss-of-function and gain-of-function
mutations in KCNQ5 cause intellectual disability or epileptic
encephalopathy. Am J Hum Genet. 101:65–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Krepischi AC, Knijnenburg J, Bertola DR,
Kim CA, Pearson PL, Bijlsma E, Szuhai K, Kok F, Vianna-Morgante AM
and Rosenberg C: Two distinct regions in 2q24.2-q24.3 associated
with idiopathic epilepsy. Epilepsia. 51:2457–2460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Liang JS, Lin LJ, Yang MT, Wang JS and Lu
JF: The therapeutic implication of a novel SCN2A mutation
associated early-onset epileptic encephalopathy with Rett-like
features. Brain Dev. 39:877–881. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Davidsson J, Collin A, Olsson ME, Lundgren
J and Soller M: Deletion of the SCN gene cluster on 2q24.4 is
associated with severe epilepsy: An array-based genotype-phenotype
correlation and a comprehensive review of previously published
cases. Epilepsy Res. 81:69–79. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zaman T, Helbig I, Bozovic IB, DeBrosse
SD, Bergqvist AC, Wallis K, Medne L, Maver A, Peterlin B, Helbig
KL, et al: Mutations in SCN3A cause early infantile epileptic
encephalopathy. Ann Neurol. 83:703–717. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yang Y, Zhang YH, Chen JY, Zhang J, Yang
XL, Chen Y, Yang ZX and Wu XR: Clinical features of epilepsies
associated with GABRB2 variants. Zhonghua Er Ke Za Zhi. 57:532–537.
2019.(In Chinese). PubMed/NCBI
|
|
99
|
Butler KM, Moody OA, Schuler E, Coryell J,
Alexander JJ, Jenkins A and Escayg A: De novo variants in GABRA2
and GABRA5 alter receptor function and contribute to early-onset
epilepsy. Brain. 141:2392–2405. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Orenstein N, Goldberg-Stern H, Straussberg
R, Bazak L, Hubshman MW, Kropach N, Gilad O, Scheuerman O, Dory Y,
Kraus D, et al: A de novo GABRA2 missense mutation in severe
early-onset epileptic encephalopathy with a choreiform movement
disorder. Eur J Paediatr Neurol. 22:516–524. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang Y, Lian Y and Xie N: Early onset
epileptic encephalopathy with a novel GABRB3 mutation treated
effectively with clonazepam: A case report. Medicine (Baltimore).
96:e92732017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Hernandez CC, Zhang Y, Hu N, Shen D, Shen
W, Liu X, Kong W, Jiang Y and Macdonald RL: GABA a receptor
coupling junction and pore GABRB3 mutations are linked to
early-onset epileptic encephalopathy. Sci Rep. 7:159032017.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Farnaes L, Nahas SA, Chowdhury S, Nelson
J, Batalov S, Dimmock DM and Kingsmore SF; RCIGM Investigators, :
Rapid whole-genome sequencing identifies a novel GABRA1 variant
associated with West syndrome. Cold Spring Harb Mol Case Stud.
3(pii): a0017762017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Iqbal MJ, Wasim M, Rashid U, Zeeshan N,
Ali R, Nayyab S, Habib S, Manzoor B and Zahid N: Mutational
screening of GABRG2 gene in Pakistani population of Punjab with
generalized tonic clonic seizures and children with childhood
absence epilepsy. J Chin Med Assoc. 81:665–669. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bhat MA, Guru SA, Mir R, Waza AA, Zuberi
M, Sumi MP, Bodeliwala S, Puri V and Saxena A: Association of GABAA
receptor gene with epilepsy syndromes. J Mol Neurosci. 65:141–153.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Le SV, Le PHT, Le TKV, Huynh TTK and Do
TTH: A mutation in GABRB3 associated with Dravet syndrome. Am J Med
Genet A. 173:2126–2131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ishii A, Kang JQ, Schornak CC, Hernandez
CC, Shen W, Watkins JC, Macdonald RL and Hirose S: A de novo
missense mutation of GABRB2 causes early myoclonic encephalopathy.
J Med Genet. 54:202–211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yoo Y, Jung J, Lee YN, Lee Y, Cho H, Na E,
Hong J, Kim E, Lee JS, Lee JS, et al: GABBR2 mutations determine
phenotype in rett syndrome and epileptic encephalopathy. Ann
Neurol. 82:466–478. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Epi4K Consortium: De novo mutations in
SLC1A2 and CACNA1A are important causes of epileptic
encephalopathies. Am J Hum Genet. 99:287–298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Liu J, Tong L, Song S, Niu Y, Li J, Wu X,
Zhang J, Zai CC, Luo F, Wu J, et al: Novel and de novo mutations in
pediatric refractory epilepsy. Mol Brain. 11:482018. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Hayashida T, Saito Y, Ishii A, Yamada H,
Itakura A, Minato T, Fukuyama T, Maegaki Y and Hirose S:
CACNA1A-related early-onset encephalopathy with myoclonic epilepsy:
A case report. Brain Dev. 40:130–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Byers HM, Beatty CW, Hahn SH and Gospe SM
Jr: Dramatic response after lamotrigine in a patient with epileptic
encephalopathy and a de novo CACNA1A variant. Pediatr Neurol.
60:79–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Epperson MV, Haws ME, Standridge SM and
Gilbert DL: An atypical rett syndrome phenotype due to a novel
missense mutation in CACNA1A. J Child Neurol. 33:286–289. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Du X, Chen Y, Zhao Y, Luo W, Cen Z and Hao
W: Dramatic response to pyridoxine in a girl with absence epilepsy
with ataxia caused by a de novo CACNA1A mutation. Seizure.
45:189–191. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Heron SE, Khosravani H, Varela D, Bladen
C, Williams TC, Newman MR, Scheffer IE, Berkovic SF, Mulley JC and
Zamponi GW: Extended spectrum of idiopathic generalized epilepsies
associated with CACNA1H functional variants. Ann Neurol.
62:560–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Yoshida M, Nakashima M, Okanishi T, Kanai
S, Fujimoto A, Itomi K, Morimoto M, Saitsu H, Kato M, Matsumoto N
and Chiyonobu T: Identification of novel BCL11A variants in
patients with epileptic encephalopathy: Expanding the phenotypic
spectrum. Clin Genet. 93:368–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Kurian M, Korff CM, Ranza E, Bernasconi A,
Lübbig A, Nangia S, Ramelli GP, Wohlrab G, Nordli DR and Bast T:
Focal cortical malformations in children with early infantile
epilepsy and PCDH19 mutations: Case report. Dev Med Child Neurol.
60:100–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ko A, Youn SE, Kim SH, Lee JS, Kim S, Choi
JR, Kim HD, Lee ST and Kang HC: Targeted gene panel and genotype-
phenotype correlation in children with developmental and epileptic
encephalopathy. Epilepsy Res. 141:48–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Wang ZJ, Chen J, Chen HL, Zhang LY, Xu D
and Jiang WT: Association between SCN1A polymorphism rs3812718 and
valproic acid resistance in epilepsy children: A case-control study
and meta-analysis. Biosci Rep. 38(pii): BSR201816542018. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Margari L, Legrottaglie AR, Vincenti A,
Coppola G, Operto FF, Buttiglione M, Cassano A, Bartolomeo N and
Mariggio MA: Association between SCN1A gene polymorphisms and drug
resistant epilepsy in pediatric patients. Seizure. 55:30–35. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Ajmi M, Boujaafar S, Zouari N, Amor D,
Nasr A, Rejeb NB, Amor SB, Omezzine A, Benammou S and Bouslama A:
Association between ABCB1 polymorphisms and response to
first-generation antiepileptic drugs in a Tunisian epileptic
population. Int J Neurosci. 128:705–714. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Abou El Ella SS, Tawfik MA, Abo El Fotoh
WMM and Soliman OAM: The genetic variant ‘C588T’ of GABARG2 is
linked to childhood idiopathic generalized epilepsy and resistance
to antiepileptic drugs. Seizure. 60:39–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Skalski D, Wendorff J, Romanowicz H, Rysz
A, Marchel A, Stasiołek M and Smolarz B: Associations between MDR1
C3435T polymorphism and drug-resistant epilepsy in the Polish
population. Acta Neurol Belg. 117:153–158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
López-Garcia MA, Feria-Romero IA, Serrano
H, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C,
Grijalva I, Escalante-Santiago D and Orozco-Suarez S: Influence of
genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on
antiepileptic drug metabolism in pediatric patients with refractory
epilepsy. Pharmacol Rep. 69:504–511. 2017. View Article : Google Scholar
|
|
125
|
Lv Y, Wang Z, Liu C and Cui L:
Identification of a novel CACNA1A mutation in a Chinese family with
autosomal recessive progressive myoclonic epilepsy. Neuropsychiatr
Dis Treat. 13:2631–2636. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Kozera-Kępniak A, Jastrzębski K, Walenczak
J, Klimek A and Głąbiński A: 66034T/C polymorphism of the human
pregnane X receptor (hPXR) as potential risk factor for drug
resistance in epilepsy-Preliminary study. Neurol Neurochir Pol.
51:19–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Wang J, Gao H, Bao X, Zhang Q, Li J, Wei
L, Wu X, Chen Y and Yu S: SCN8A mutations in Chinese patients with
early onset epileptic encephalopathy and benign infantile seizures.
BMC Med Genet. 18:1042017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Parrini E, Marini C, Mei D, Galuppi A,
Cellini E, Pucatti D, Chiti L, Rutigliano D, Bianchini C, Virdo S,
et al: Diagnostic targeted resequencing in 349 patients with
drug-resistant pediatric epilepsies identifies causative mutations
in 30 different genes. Hum Mutat. 38:216–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Kimizu T, Takahashi Y, Oboshi T, Horino A,
Koike T, Yoshitomi S, Mori T, Yamaguchi T, Ikeda H, Okamoto N, et
al: A case of early onset epileptic encephalopathy with de novo
mutation in SLC35A2: Clinical features and treatment for epilepsy.
Brain Dev. 39:256–260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Shen D, Hernandez CC, Shen W, Hu N, Poduri
A, Shiedley B, Rotenberg A, Datta AN, Leiz S, Patzer S, et al: De
novo GABRG2 mutations associated with epileptic encephalopathies.
Brain. 140:49–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhang Q, Li J, Zhao Y, Bao X, Wei L and
Wang J: Gene mutation analysis of 175 Chinese patients with
early-onset epileptic encephalopathy. Clin Genet. 91:717–724. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Miao P, Peng J, Chen C, Gai N and Yin F: A
novel mutation in KCNB1 gene in a child with neuropsychiatric
comorbidities with both intellectual disability and epilepsy and
review of literature. Zhonghua Er Ke Za Zhi. 55:115–119. 2017.(In
Chinese). PubMed/NCBI
|
|
133
|
Perucca P, Scheffer IE, Harvey AS, James
PA, Lunke S, Thorne N, Gaff C, Regan BM, Damiano JA, Hildebrand MS,
et al: Real-world utility of whole exome sequencing with targeted
gene analysis for focal epilepsy. Epilepsy Res. 131:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Guo M, Wang J, Qi H, Liu F, Yao L, Zhang S
and Li K: Polymorphisms in the receptor for advanced glycation end
products gene are associated with susceptibility to drug-resistant
epilepsy. Neurosci Lett. 619:137–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Stasiołek M, Romanowicz H, Połatyńska K,
Chamielec M, Skalski D, Makowska M and Smolarz B: Association
between C3435T polymorphism of MDR1 gene and the incidence of
drug-resistant epilepsy in the population of Polish children. Behav
Brain Funct. 12:212016. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Abo El Fotoh WM, Abd El Naby SA, Habib MS,
ALrefai AA and Kasemy ZA: The potential implication of SCN1A and
CYP3A5 genetic variants on antiepileptic drug resistance among
Egyptian epileptic children. Seizure. 41:75–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Xue T and Lu ZN: Association between the
polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and
the risk of drug-resistant epilepsy in a Chinese Han population.
Genet Mol Res. 15:2016. View Article : Google Scholar :
|
|
138
|
Moen MN, Fjaer R, Hamdani EH, Laerdahl JK,
Menchini RJ, Vigeland MD, Sheng Y, Undlien DE, Hassel B, Salih MA,
et al: Pathogenic variants in KCTD7 perturb neuronal K+
fluxes and glutamine transport. Brain. 139:3109–3120. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Hildebrand MS, Griffin NG, Damiano JA,
Cops EJ, Burgess R, Ozturk E, Jones NC, Leventer RJ, Freeman JL,
Harvey AS, et al: Mutations of the sonic hedgehog pathway underlie
hypothalamic hamartoma with gelastic epilepsy. Am J Hum Genet.
99:423–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Hardies K, Cai Y, Jardel C, Jansen AC, Cao
M, May P, Djémié T, Hachon Le Camus C, Keymolen K, Deconinck T, et
al: Loss of SYNJ1 dual phosphatase activity leads to early onset
refractory seizures and progressive neurological decline. Brain.
139:2420–2430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Lionel AC, Monfared N, Scherer SW,
Marshall CR and Mercimek-Mahmutoglu S: MED23-associated refractory
epilepsy successfully treated with the ketogenic diet. Am J Med
Genet A. 170:2421–2425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Balestrini S, Milh M, Castiglioni C, Lüthy
K, Finelli MJ, Verstreken P, Cardon A, Stražišar BG, Holder JL Jr,
Lesca G, et al: TBC1D24 genotype-phenotype correlation: Epilepsies
and other neurologic features. Neurology. 87:77–85. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Fahrner JA, Liu R, Perry MS, Klein J and
Chan DC: A novel de novo dominant negative mutation in DNM1L
impairs mitochondrial fission and presents as childhood epileptic
encephalopathy. Am J Med Genet A. 170:2002–2011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Vanstone JR, Smith AM, McBride S, Naas T,
Holcik M, Antoun G, Harper ME, Michaud J, Sell E, Chakraborty P, et
al: DNM1L-related mitochondrial fission defect presenting as
refractory epilepsy. Eur J Hum Genet. 24:1084–1088. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Janssen W, Quaegebeur A, Van Goethem G,
Ann L, Smets K, Vandenberghe R and Van Paesschen W: The spectrum of
epilepsy caused by POLG mutations. Acta Neurol Belg. 116:17–25.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED,
Tian L, McCormick EM, Kosobucki GJ, Chen W, Schulien AJ, Chiavacci
R, et al: GRIN2D recurrent de novo dominant mutation causes a
severe epileptic encephalopathy treatable with NMDA receptor
channel blockers. Am J Hum Genet. 99:802–816. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Segal E, Pedro H, Valdez-Gonzalez K,
Parisotto S, Gliksman F, Thompson S, Sabri J and Fertig E:
Diagnostic yield of epilepsy panels in children with
medication-refractory epilepsy. Pediatr Neurol. 64:66–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Palmer S, Towne MC, Pearl PL, Pelletier
RC, Genetti CA, Shi J, Beggs AH, Agrawal PB and Brownstein CA:
SLC6A1 mutation and ketogenic diet in epilepsy with
myoclonic-atonic seizures. Pediatr Neurol. 64:77–79. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Inui T, Kobayashi S, Ashikari Y, Sato R,
Endo W, Uematsu M, Oba H, Saitsu H, Matsumoto N, Kure S and
Haginoya K: Two cases of early-onset myoclonic seizures with
continuous parietal delta activity caused by EEF1A2 mutations.
Brain Dev. 38:520–524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Horta WG, Paradela E, Figueiredo A, Meira
ID, Pereira VC, Rego CC, Oliveira R, Andraus ME, de Lacerda GC,
Moura P, et al: Genetic association study of the HLA class II
alleles DRB1, DQA1, and DQB1 in patients with pharmacoresistant
temporal lobe epilepsy associated with mesial hippocampal
sclerosis. Seizure. 31:7–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Damiano JA, Afawi Z, Bahlo M, Mauermann M,
Misk A, Arsov T, Oliver KL, Dahl HH, Shearer AE, Smith RJ, et al:
Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus
epilepsy with early ataxia. Hum Mol Genet. 24:4483–4490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Bene J, Hadzsiev K, Komlósi K, Kövesdi E,
Mátyás P and Melegh B: De novo SCN1A gene deletion in
therapy-resistant Dravet syndrome. Orv Hetil. 156:2009–2012.
2015.(In Hungarian). View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Berghuis B, de Kovel CG, van Iterson L,
Lamberts RJ, Sander JW, Lindhout D and Koeleman BP: Complex SCN8A
DNA-abnormalities in an individual with therapy resistant absence
epilepsy. Epilepsy Res. 115:141–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Damaj L, Lupien-Meilleur A, Lortie A, Riou
É, Ospina LH, Gagnon L, Vanasse C and Rossignol E: CACNA1A
haploinsufficiency causes cognitive impairment, autism and
epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum
Genet. 23:1505–1512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Guo Y, Yan KP, Qu Q, Qu J, Chen ZG, Song
T, Luo XY, Sun ZY, Bi CL and Liu JF: Common variants of KCNJ10 are
associated with susceptibility and anti-epileptic drug resistance
in Chinese genetic generalized epilepsies. PLoS One.
10:e01248962015. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Liu Z, Yin X, Liu L, Tao H, Zhou H, Ma G,
Cui L, Li Y, Zhang S, Xu Z, et al: Association of KEAP1 and NFE2L2
polymorphisms with temporal lobe epilepsy and drug resistant
epilepsy. Gene. 571:231–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Emich-Widera E, Likus W, Kazek B, Sieron
AL and Urbanek K: Polymorphism of ABCB1/MDR1 C3435T in children and
adolescents with partial epilepsy is due to different criteria for
drug resistance-preliminary results. Med Sci Monit. 20:1654–1661.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Venkateswaran S, Myers KA, Smith AC,
Beaulieu CL, Schwartzentruber JA; FORGE Canada Consortium, ;
Majewski J, Bulman D, Boycott KM and Dyment DA: Whole-exome
sequencing in an individual with severe global developmental delay
and intractable epilepsy identifies a novel, de novo GRIN2A
mutation. Epilepsia. 55:e75–e79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Picard F, Makrythanasis P, Navarro V,
Ishida S, de Bellescize J, Ville D, Weckhuysen S, Fosselle E, Suls
A, De Jonghe P, et al: DEPDC5 mutations in families presenting as
autosomal dominant nocturnal frontal lobe epilepsy. Neurology.
82:2101–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Martin HC, Kim GE, Pagnamenta AT, Murakami
Y, Carvill GL, Meyer E, Copley RR, Rimmer A, Barcia G, Fleming MR,
et al: Clinical whole-genome sequencing in severe early-onset
epilepsy reveals new genes and improves molecular diagnosis. Hum
Mol Genet. 23:3200–3211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Seven M, Batar B, Unal S, Yesil G, Yuksel
A and Guven M: The drug-transporter gene MDR1 C3435T and G2677T/A
polymorphisms and the risk of multidrug-resistant epilepsy in
Turkish children. Mol Biol Rep. 41:331–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Escalante-Santiago D, Feria-Romero IA,
Ribas-Aparicio RM, Rayo-Mares D, Fagiolino P, Vázquez M,
Escamilla-Núñez C, Grijalva-Otero I, López-Garcia MA and
Orozco-Suárez S: MDR-1 and MRP2 gene polymorphisms in mexican
epileptic pediatric patients with complex partial seizures. Front
Neurol. 5:1842014. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Seven M, Batar B, Unal S, Yesil G, Yuksel
A and Guven M: The effect of genetic polymorphisms of cytochrome
P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in
Turkish children. Mol Diagn Ther. 18:229–236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Ma CL, Wu XY, Zheng J, Wu ZY, Hong Z and
Zhong MK: Association of SCN1A, SCN2A and ABCC2 gene polymorphisms
with the response to antiepileptic drugs in Chinese Han patients
with epilepsy. Pharmacogenomics. 15:1323–1336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
He X, Li Y, Liu Z, Yue X, Zhao P, Hu J, Wu
G, Mao B, Sun D, Zhang H, et al: The association between CCL2
polymorphisms and drug-resistant epilepsy in Chinese children.
Epileptic Disord. 15:272–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Serino D, Specchio N, Pontrelli G,
Vigevano F and Fusco L: Video/EEG findings in a KCNQ2 epileptic
encephalopathy: A case report and revision of literature data.
Epileptic Disord. 15:158–165. 2013.PubMed/NCBI
|
|
167
|
Emich-Widera E, Likus W, Kazek B, Niemiec
P, Balcerzyk A, Sieroń AL and Zak I: CYP3A5*3 and C3435T MDR1
polymorphisms in prognostication of drug-resistant epilepsy in
children and adolescents. Biomed Res Int. 2013:5268372013.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Veeramah KR, Johnstone L, Karafet TM, Wolf
D, Sprissler R, Salogiannis J, Barth-Maron A, Greenberg ME,
Stuhlmann T, Weinert S, et al: Exome sequencing reveals new causal
mutations in children with epileptic encephalopathies. Epilepsia.
54:1270–1281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Fragaki K, Ait-El-Mkadem S, Chaussenot A,
Gire C, Mengual R, Bonesso L, Beneteau M, Ricci JE, Desquiret-Dumas
V, Procaccio V, et al: Refractory epilepsy and mitochondrial
dysfunction due to GM3 synthase deficiency. Eur J Hum Genet.
21:528–534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Subenthiran S, Abdullah NR, Joseph JP,
Muniandy PK, Mok BT, Kee CC, Ismail Z and Mohamed Z: Linkage
disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict
the treatment outcome of Malaysians with complex partial seizures
on treatment with carbamazepine mono-therapy at the Kuala Lumpur
Hospital. PLoS One. 8:e648272013. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei
GH, Tang Q, Zhou HH and Liu ZQ: ABCC2 polymorphisms and haplotype
are associated with drug resistance in Chinese epileptic patients.
CNS Neurosci Ther. 18:647–651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Dimova PS, Kirov A, Todorova A, Todorov T
and Mitev V: A novel PCDH19 mutation inherited from an unaffected
mother. Pediatr Neurol. 46:397–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Sayyah M, Kamgarpour F, Maleki M,
Karimipoor M, Gharagozli K and Shamshiri AR: Association analysis
of intractable epilepsy with C3435T and G2677T/A ABCB1 gene
polymorphisms in Iranian patients. Epileptic Disord. 13:155–165.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Lakhan R, Kumari R, Singh K, Kalita J,
Misra UK and Mittal B: Possible role of CYP2C9 & CYP2C19 single
nucleotide polymorphisms in drug refractory epilepsy. Indian J Med
Res. 134:295–301. 2011.PubMed/NCBI
|
|
175
|
Kumari R, Lakhan R, Garg RK, Kalita J,
Misra UK and Mittal B: Pharmacogenomic association study on the
role of drug metabolizing, drug transporters and drug target gene
polymorphisms in drug-resistant epilepsy in a north Indian
population. Indian J Hum Genet. 17 (Suppl 1):S32–S40. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Kwan P, Wong V, Ng PW, Lui CH, Sin NC,
Wong KS and Baum L: Gene-wide tagging study of the association
between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug
resistance in epilepsy. Pharmacogenomics. 12:319–325. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Kim DU, Kim MK, Cho YW, Kim YS, Kim WJ,
Lee MG, Kim SE, Nam TS, Cho KH, Kim YO and Lee MC: Association of a
synonymous GAT3 polymorphism with antiepileptic drug
pharmacoresistance. J Hum Genet. 56:640–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Meng H, Guo G, Ren J, Zhou H, Ge Y and Guo
Y: Effects of ABCB1 polymorphisms on plasma carbamazepine
concentrations and pharmacoresistance in Chinese patients with
epilepsy. Epilepsy Behav. 21:27–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Alpman A, Ozkinay F, Tekgul H, Gokben S,
Pehlivan S, Schalling M and Ozkinay C: Multidrug resistance 1
(MDR1) gene polymorphisms in childhood drug-resistant epilepsy. J
Child Neurol. 25:1485–1490. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Maleki M, Sayyah M, Kamgarpour F,
Karimipoor M, Arab A, Rajabi A, Gharagozli K, Shamshiri AR and
Shahsavand Ananloo E: Association between ABCB1-T1236C polymorphism
and drug-resistant epilepsy in Iranian female patients. Iran Biomed
J. 14:89–96. 2010.PubMed/NCBI
|
|
181
|
Di Bonaventura C, Carni M, Diani E,
Fattouch J, Vaudano EA, Egeo G, Pantano P, Maraviglia B, Bozzao L,
Manfredi M, et al: Drug resistant ADLTE and recurrent partial
status epilepticus with dysphasic features in a family with a novel
LGI1mutation: Electroclinical, genetic, and EEG/fMRI findings.
Epilepsia. 50:2481–2486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Jang SY, Kim MK, Lee KR, Park MS, Kim BC,
Cho KH, Lee MC and Kim YS: Gene-to-gene interaction between sodium
channel-related genes in determining the risk of antiepileptic drug
resistance. J Korean Med Sci. 24:62–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Vahab SA, Sen S, Ravindran N, Mony S,
Mathew A, Vijayan N, Nayak G, Bhaskaranand N, Banerjee M and
Satyamoorthy K: Analysis of genotype and haplotype effects of ABCB1
(MDR1) polymorphisms in the risk of medically refractory epilepsy
in an Indian population. Drug Metab Pharmacokinet. 24:255–260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Kwan P, Wong V, Ng PW, Lui CH, Sin NC,
Poon WS, Ng HK, Wong KS and Baum L: Gene-wide tagging study of
association between ABCB1 polymorphisms and multidrug resistance in
epilepsy in Han Chinese. Pharmacogenomics. 10:723–732. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Kauffman MA, Consalvo D, Gonzalez-Morón D,
Aguirre F, D'Alessio L and Kochen S: Serotonin transporter gene
variation and refractory mesial temporal epilepsy with hippocampal
sclerosis. Epilepsy Res. 85:231–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lakhan R, Kumari R, Misra UK, Kalita J,
Pradhan S and Mittal B: Differential role of sodium channels SCN1A
and SCN2A gene polymorphisms with epilepsy and multiple drug
resistance in the north Indian population. Br J Clin Pharmacol.
68:214–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Bahi-Buisson N, Nectoux J, Rosas-Vargas H,
Milh M, Boddaert N, Girard B, Cances C, Ville D, Afenjar A, Rio M,
et al: Key clinical features to identify girls with CDKL5
mutations. Brain. 131:2647–2661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Kwan P, Poon WS, Ng HK, Kang DE, Wong V,
Ng PW, Lui CH, Sin NC, Wong KS and Baum L: Multidrug resistance in
epilepsy and polymorphisms in the voltage-gated sodium channel
genes SCN1A, SCN2A, and SCN3A: Correlation among phenotype,
genotype, and mRNA expression. Pharmacogenet Genom. 18:989–998.
2008. View Article : Google Scholar
|
|
189
|
Elia M, Falco M, Ferri R, Spalletta A,
Bottitta M, Calabrese G, Carotenuto M, Musumeci SA, Lo Giudice M
and Fichera M: CDKL5 mutations in boys with severe encephalopathy
and early-onset intractable epilepsy. Neurology. 71:997–999. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Abe T, Seo T, Ishitsu T, Nakagawa T, Hori
M and Nakagawa K: Association between SCN1A polymorphism and
carbamazepine-resistant epilepsy. Br J Clin Pharmacol. 66:304–307.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Shahwan A, Murphy K, Doherty C, Cavalleri
GL, Muckian C, Dicker P, McCarthy M, Kinirons P, Goldstein D and
Delanty N: The controversial association of ABCB1 polymorphisms in
refractory epilepsy: An analysis of multiple SNPs in an Irish
population. Epilepsy Res. 73:192–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin
NC, Hui AC, Yu E and Wong LK: Association between ABCB1 C3435T
polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy
Behav. 11:112–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Hung CC, Jen Tai J, Kao PJ, Lin MS and
Liou HH: Association of polymorphisms in NR1I2 and ABCB1 genes with
epilepsy treatment responses. Pharmacogenomics. 8:1151–1158. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Leschziner GD, Jorgensen AL, Andrew T,
Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ,
Rogers J, Bentley DR, et al: The association between polymorphisms
in RLIP76 and drug response in epilepsy. Pharmacogenomics.
8:1715–1722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Seo T, Ishitsu T, Ueda N, Nakada N, Yurube
K, Ueda K and Nakagawa K: ABCB1 polymorphisms influence the
response to antiepileptic drugs in Japanese epilepsy patients.
Pharmacogenomics. 7:551–561. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Hung CC, Tai JJ, Lin CJ, Lee MJ and Liou
HH: Complex haplotypic effects of the ABCB1 gene on epilepsy
treatment response. Pharmacogenomics. 6:411–417. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Mills PB, Surtees RA, Champion MP, Beesley
CE, Dalton N, Scambler PJ, Heales SJ, Briddon A, Scheimberg I,
Hoffmann GF, et al: Neonatal epileptic encephalopathy caused by
mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate
oxidase. Hum Mol Genet. 14:1077–1086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Buono RJ, Lohoff FW, Sander T, Sperling
MR, O'Connor MJ, Dlugos DJ, Ryan SG, Golden GT, Zhao H, Scattergood
TM, et al: Association between variation in the human KCNJ10
potassium ion channel gene and seizure susceptibility. Epilepsy
Res. 58:175–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Siddiqui A, Kerb R, Weale ME, Brinkmann U,
Smith A, Goldstein DB, Wood NW and Sisodiya SM: Association of
multidrug resistance in epilepsy with a polymorphism in the
drug-transporter gene ABCB1. N Engl J Med. 348:1442–1448. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Gambardella A, Manna I, Labate A, Chifari
R, La Russa A, Serra P, Cittadella R, Bonavita S, Andreoli V,
LePiane E, et al: GABA(B) receptor 1 polymorphism (G1465A) is
associated with temporal lobe epilepsy. Neurology. 60:560–563.
2003. View Article : Google Scholar : PubMed/NCBI
|
